Archana Ayyar,Rebecca Flyckt
Archana Ayyar
Aaron D Masjedi,Sarah C Cromack
Aaron D Masjedi
First European live birth following uterine and adnexal transposition for fertility preservation: a case report and overview of reported neonatal outcomes [0.03%]
欧洲首例卵巢和附件移位后出生婴儿病例报告及报道的新生儿结局概述
Daniela Huber,Deborah Wernly
Daniela Huber
Objective: To report the first live birth in Europe, and the fifth worldwide, after uterine and adnexal transposition (UT) for fertility preservation in rectal cancer, and to review all published neonatal outcomes after U...
Case Reports
F&S reports. 2026 Jan 30;7(2):120-124. DOI:10.1016/j.xfre.2026.01.004 2026
Reproductive medicine care in BRCA mutation carriers: an opportunity for early intervention [0.03%]
BRCA基因突变携带者的生殖医学护理：早期干预的机会
Ecem Esencan,Kara N Goldman
Ecem Esencan
Reproductive outcomes after fertility preservation using tamoxifen or letrozole in women with breast cancer: a long-term follow-up [0.03%]
他莫昔芬或来曲唑用于乳腺癌患者生育力保存后的生殖结局：长期随访结果
Bo F Paans,Madelon van Wely,Catharina C M Beerendonk et al.
Bo F Paans et al.
Objective: To evaluate long-term pregnancy outcomes in young women with breast cancer after ovarian stimulation for fertility preservation, with the addition of tamoxifen or letrozole to standard stimulation vs. no additi...
Frozen embryo transfer outcomes in patients with prior cesarean delivery: a focus on endometrial lining parameters [0.03%]
子宫内膜厚度和模式影响既往有剖宫产史患者冻融胚胎移植结局
Emily A Clarke,Jing Wu,Hannah Milad et al.
Emily A Clarke et al.
Objective: To evaluate the association between prior mode of delivery (cesarean vs. vaginal) and endometrial thickness in the subsequent frozen embryo transfer (FET) cycle. The secondary aim was to evaluate FET cycle outc...
Quantification of per- and polyfluoroalkyl substances in plasma and follicular fluid of patients undergoing in vitro fertilization in Iowa: A pilot study [0.03%]
碘海醇在体外受精患者血浆和卵泡液中聚和多氟烷基物质的量化：一项初步研究
Prapti Singh-Herren,Samantha Good,Karen M Summers et al.
Prapti Singh-Herren et al.
Impact of estetrol and drospirenone combination therapy on alleviation of the pelvic pain of endometriosis: a randomized control trial [0.03%]
雌莫孕素和屈螺酮联合治疗子宫内膜异位症盆腔痛的疗效观察：随机对照试验
Tasuku Harada,Masayoshi Nogami,Masato Iizuka et al.
Tasuku Harada et al.
Objective: To study the impact of estetrol (E4), a novel native estrogen with selective tissue activity, on endometriosis-associated pelvic pain (EAPP) and global impressions of endometriosis pain. ...
A single biomarker may not yield a reliable binary clinical answer: B cell lymphoma 6 testing and resulting interventions for endometriosis in infertility care [0.03%]
单一生物标志物无法提供可靠的二元临床答案：B细胞淋巴瘤6检测及在不孕症治疗中产生的干预措施用于子宫内膜异位症患者
Arti Taggar,Amanda Ulrich,Yuliana Tan et al.
Arti Taggar et al.
Objective: To study the associations of B cell lymphoma 6 (BCL6) in endometrial endometriosis, and to determine a practice's experience testing BCL6 in patients with recurrent pregnancy loss/recurrent implantation failure...
Reply of the Authors: Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial [0.03%]
作者回信：针对内异症长效抗白细胞介素-8抗体AMY109的安全性与药理学：一项双盲随机Ⅰ期试验
Peng-Hui Wang,Chun-An Chen,Mayuko Sekiya et al.
Peng-Hui Wang et al.